Publication Name	World Journal of Hepatology
Manuscript ID	28775
Country	Spain

Received	2016-07-15 21:57
Peer-Review Started	2016-07-18 10:30
To Make the First Decision	2016-08-04 18:25
Return for Revision	2016-08-16 17:54
Revised	2016-09-03 20:33
Second Decision	2016-09-30 11:17
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-10-18 16:54
Articles in Press	2016-10-18 16:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-01-11 14:43
Publish the Manuscript Online	2017-01-22 08:28

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Case Report
Article Title	Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin
Manuscript Source	Unsolicited Manuscript
All Author List	Maria Pilar Ballester-Ferré, Fernando Martínez, Natalia Garcia-Gimeno, Francisco Mora and Miguel A Serra
Funding Agency and Grant Number
Corresponding Author	Maria Pilar Ballester-Ferré, MD, Gastroenterology and Hepatology Department, University Clinic Hospital of Valencia, University of Valencia, Blasco Ibañez, 17, 46010 Valencia, Spain. mapibafe@gmail.com
Key Words	Tuberculosis; Ledipasvir; Ribavirin; Sofosbuvir; Hepatitis C
Core Tip	Cases of tuberculosis (TB) infection have been identified with α-interferon-based therapy and the triple therapy with pegylated-interferon, ribavirin and boceprevir or telaprevir. This is the first case of a TB infection during treatment with sofosbuvir/ledipasvir plus ribavirin. It is relevant to increase awareness of TB due to its variety of symptoms, which can be confused with those associated to the hepatitis C virus or the antiviral treatment. Considering the impaired immune system of cirrhotic patients and that these drugs arrived slightly more than one year ago it is important to be conscious of the potential events that can be related with the treatment.
Publish Date	2017-01-22 08:28
Citation	Ballester-Ferré MP, Martínez F, Garcia-Gimeno N, Mora F, Serra MA. Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin. World J Hepatol 2017; 9(3): 161-166
URL	http://www.wjgnet.com/1948-5182/full/v9/i3/161.htm
DOI	http://dx.doi.org/10.4254/wjh.v9.i3.161

Full Article (PDF)	WJH-9-161.pdf
Full Article (Word)	WJH-9-161.doc
Manuscript File	28775-Review.doc
Answering Reviewers	28775-Answering reviewers.pdf
Audio Core Tip	28775-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	28775-Conflict-of-interest statement.pdf
Copyright License Agreement	28775-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	28775-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	28775-Language certificate.pdf
Peer-review Report	28775-Peer-review(s).pdf
Scientific Misconduct Check	28775-Scientific misconduct check.pdf
Scientific Editor Work List	28775-Scientific editor work list.pdf